News

Scientists have discovered, using preclinical models, that they can overcome chemotherapy resistance in an ovarian cancer subtype by using low doses of a drug which slows cell growth.

Researchers have characterized how the gut microbiome develops in the first hours of infancy, providing a critical baseline for how changes in this environment can impact health and disease later in life.

Researchers have been working to understand the genetic basis of Mitchell disease, a rare neurodegenerative disorder.

The end of soy as a protein substitute? Researchers have found a way to make protein powder using fava beans — a far more climate-friendly alternative.

Scientists from DTU Biosustain prove that psilocybin, a potential drug for treating depression and other psychological conditions can be produced in yeast.

Experts recommend that children do not consume drinks with added sugars or nonnutritive sweeteners, yet drinks containing both represent a major portion of beverages consumed by children. One reason may be that the labels of drinks marketed to kids do not help parents and other consumers differentiate among fruit juice and sugar-laden, artificially flavored drinks.

The seven comprehensive cancer centres of Cancer Core Europe (CCE), have shared how they were able to rapidly reorganize their cancer healthcare systems during the COVID-19 pandemic. In this joint effort, the centers offer guidance to institutions globally by outlining the strategies they adopted to make their operations "pandemic proof".

Physicists have taken a step towards understanding why the universe is made of mostly matter and not antimatter, by studying the difference between the two.

Researchers at Calibr, the drug development division of Scripps Research, are teaming up with scientists across the globe to screen a vast collection of compounds, in the hunt for individual drugs or combinations of drugs that may be effective in treating people exposed to COVID-19.

Researchers have discovered that in mice — and probably humans as well — one biological chaperone may play a key role in protection from autoimmune responses.